These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22012766)
1. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder. Liu DC; Yang ZL Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106 [TBL] [Abstract][Full Text] [Related]
3. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. Xiong L; Yang Z; Yang L; Liu J; Miao X J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153 [TBL] [Abstract][Full Text] [Related]
4. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder]. Liu DC; Yang ZL Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571 [TBL] [Abstract][Full Text] [Related]
5. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder. Yang L; Guo T; Jiang S; Yang Z Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma. Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866 [TBL] [Abstract][Full Text] [Related]
7. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma. Yuan LW; Liu DC; Yang ZL Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074 [TBL] [Abstract][Full Text] [Related]
8. Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression. Chen PX; Li QY; Yang Z Pathol Oncol Res; 2015 Sep; 21(4):1133-40. PubMed ID: 25971681 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma. Jiang S; Pei L; Yang ZL; Liu G Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038 [TBL] [Abstract][Full Text] [Related]
10. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder. Shu GS; Yang LP; Yang ZL; Jiang S Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157 [TBL] [Abstract][Full Text] [Related]
11. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder. Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706 [TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase and glutamate decarboxylase 65 as prognostic markers of gallbladder malignancy: a clinicopathological study in benign and malignant lesions of the gallbladder. Deng X; Pei D Mol Med Rep; 2013 Feb; 7(2):413-8. PubMed ID: 23152127 [TBL] [Abstract][Full Text] [Related]
13. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas. Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder. Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600 [TBL] [Abstract][Full Text] [Related]
15. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder. Yang L; Lan S; Liu J; Yang Z Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336 [TBL] [Abstract][Full Text] [Related]
16. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Liu DC; Yang ZL Diagn Cytopathol; 2013 Mar; 41(3):199-205. PubMed ID: 21964981 [TBL] [Abstract][Full Text] [Related]
17. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631 [TBL] [Abstract][Full Text] [Related]
18. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer. Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335 [TBL] [Abstract][Full Text] [Related]
19. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496 [TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer. Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]